FDA approves Amgen's cholesterol drug Repatha

WASHINGTON, Aug 27 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's drug Repatha for patients with hereditary forms of high cholesterol and those at high risk of cardiovascular disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.